http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019189720-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
| filingDate | 2019-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4f1af7b4a1abe385ede433e930f739d |
| publicationDate | 2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019189720-A1 |
| titleOfInvention | Aqueous liquid formulation |
| abstract | The purpose of the present invention is to provide pharmaceutical technology that makes it possible to obtain at least preservation efficacy equal to or exceeding a level at which bacteriostatic action is observed in an aqueous liquid formulation containing brimonidine and/or a salt thereof without mixing preservatives into said aqueous liquid formulation. An aqueous liquid formulation containing brimonidine and/or a salt thereof, edetic acid and/or a salt thereof, and a buffer agent makes it possible to obtain at least preservation efficacy at a level at which bacteriostatic action is observed despite said aqueous liquid formulation containing substantially no preservatives. |
| priorityDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.